Focused Ultrasound Helps Release Neurodegenerative Disorder Biomarkers
A noninvasive, focused-ultrasound-mediated liquid biopsy could help facilitate diagnosis of neurodegenerative disorders.
Category: Dementias & Alzheimer’s
Dementias & Alzheimer’s
Latest
Dementias & Alzheimer’s
Latest
Piwi-interacting RNA Discovery Lays Groundwork for New Diagnostic Technologies
Researchers have discovered a correlation between Piwi-interacting RNA and brain inflammation, which will lead to new diagnostic techniques.
Dementias & Alzheimer’s
Latest
New Biomarker Could Help Diagnose Alzheimer’s Disease Early
Researchers identified a biomarker that can help physicians diagnose Alzheimer’s earlier, as patients transition to cognitive impairment.
Molecular Brain Changes Linked to APOE4, the Main Susceptibility Gene for Alzheimer’s
It is well established that APOE4, a variant of the apolipoprotein E gene, carries a strong risk for Alzheimer’s disease.
Read More
Sensor-Based Early Detection of Age-Related Diseases from Home
Research shows how large-scale, sensor-based health monitoring can address age-related diseases and health problems that are discovered late.
Read More
Study Finds New Dementia Risk Genes Via Novel Testing Approach
A new study identified multiple new risk genes for Alzheimer’s disease and a rare, related brain disorder through new testing methods.
Read More
FDA Grants Breakthrough Device Designation for Roche Alzheimer’s Early-Detection Solution
The FDA granted Roche Breakthrough Device Designation for its Elecsys Amyloid Plasma Panel, designed to enable earlier Alzheimer’s detection.
Read More
Primary Progressive Aphasia Now More Detectible
A new, free, online, clinician-administered tool could greatly increase the likelihood of early of primary progressive aphasia detection.
Read More
Peptide ‘Fingerprint’ Enables Earlier Alzheimer’s Diagnosis
Many neurodegenerative diseases, like Alzheimer’s, have been attributed to misfolding of proteins and peptides.
Read More
Sensor May Detect Alzheimer’s More Than a Decade Early
An immuno-infrared sensor can identify signs of Alzheimer’s in the blood up to 17 years before the first clinical symptoms appear.
Read More
Alzheimer’s Biomarker Can Predict Postoperative Delirium
Clinical studies have demonstrated a strong association between Alzheimer’s disease (AD) and postoperative delirium.
Read More
Overlooked Proteins May Help Better Diagnose Alzheimer’s Disease
A relatively unstudied protein associated with neurodegeneration may better diagnose and treat Alzheimer’s disease.
Read More
Biomarker Developed for Parkinson’s Disease Diagnosis
Researchers have successfully developed a biomarker that will enable Parkinson’s to be rapidly and inexpensively diagnosed via liquid biopsy.
Read More
Comorbidities Can Increase Plasma Biomarker Levels Associated with Alzheimer’s Disease
More research is needed regarding blood tests for Alzheimer’s disease before the tests are routinely used in the clinical diagnostic setting.
Read More
In Vitro Diagnostic Test for Alzheimer’s Disease Receives Marketing Authorization
The Lumipulse G β-Amyloid Ratio (1-42/1-40) in vitro diagnostic is an FDA-authorized test to aid in the assessment of Alzheimer’s disease.
Read More
Supplement May Treat Menopausal Symptoms, Lower Risk of Alzheimer’s in Women
A clinical trial is testing a plant-based alternative to hormone therapy to reduce menopausal symptoms and the risk of Alzheimer’s in women.
Read More
Blood Biomarker Predicts Dementia Before Symptoms Show
Research has identified a blood biomarker that could help identify people with the earliest signs of dementia, before the onset of symptoms.
Read More
Albert Einstein College of Medicine Gets $4.2M Grant to Find Alzheimer’s Behavioral Markers
Researchers at Albert Einstein College of Medicine have been awarded a $4.2 million NIH grant to detect behavioral markers for Alzheimer’s.
Read More